bioRxiv Science⌕ Search

Biology subjects

Okletey, J.

Publications and source records attributed to Okletey, J..

3 recordsLinked to original sources

Nuclear DNA Damage Response Triggers Reorganization of Mitochondrial Nucleic Acids

Mitochondria are subcellular organelles responsible for energy production, and a hub for several cellular signaling pathways that ultimately control cellular processes ranging from cell death to innate immunity. Genotoxic stress, including cellular irradiation, has been shown to cause the mitochondrial-dependent activation of innate immunity via release of mitochondrial nucleic acids in the cytosol. Yet, how the other cellular events triggered by genotoxic stress affects mitochondria and mitochondrial immunity is largely unexplored. Nuclear DNA damage responses (DDR) are a set of well-described responses to genotoxic stressors that allow the cells to, through characterized mechanisms including transcriptional responses and checkpoint activation, survive or die. Whether canonical DDR directly influence mitochondrial structure and activation of downstream pathways of immunity remains unclear. Here, we identify mito-blobs: enlarged TOMM20-positive mitochondrial structures induced by genotoxic stress that are enriched for TFAM-marked mitochondrial DNA nucleoids, FASTKD2-positive mitochondrial RNA granules, and immunogenic double-stranded RNA. While structurally resembling other mitochondria stress responsive rearrangements, mito-blobs carry the distinctive feature of being induced by nuclear DNA double-stranded breaks alone. Strikingly, mitochondrial double-stranded breaks failed to induce mito-blobs, indicating nuclear-to-mitochondrial signaling rather than an autonomous response to mitochondrial genome damage. Mechanistically, we show that mito-blobs formation strictly requires MFN1/2- and OPA1-dependent fusion machinery, while nuclear DNA damage invokes a classical ATM-p53 response, which lead to cell cycle block in the G1 phase that reduce DRP1 S616 phosphorylation and shifting mitochondrial morphology toward a low-fission pro-fusion state. Strikingly, the use of the standard of care CDK4/6 inhibitor palbociclib, was sufficient to trigger mito-blobs without nuclear DNA damage. Considering the mito-blobs high content in nucleic acids, we additionally investigated if affecting their life cycle could perturb inflammatory and interferon-associated gene expression downstream of genotoxic stress. We describe how autophagic-lysosomal clearance triggered upon cell cycle block limited mito-blob persistence, and blocking autophagy disposal unmasked a strong inflammatory response. Taken together, these findings suggest mito-blobs are the product of an active mitochondrial remodeling process elicited in response to nuclear genotoxic stress and that concentrate immunogenic mitochondrial nucleic acids in defined structures for their correct disposal via autophagy and avoid aberrant activation of innate immunity. HighlightsO_LIGenotoxic stress induces enlarged mitochondrial structures called mito-blobs. C_LIO_LIMito-blobs concentrate mitochondrial DNA, RNA granules, and double-stranded RNA. C_LIO_LINuclear DNA damage, but not mitochondrial, is sufficient to induce mito-blobs. C_LIO_LICDK4 Inhibitors Trigger Mito-blob Formation. C_LIO_LIMito-blob formation and clearance alter inflammatory gene expression. C_LI eTOC blurbYu et al. identify mito-blobs as enlarged mitochondrial structures that form after genotoxic stress. They show that nuclear DNA breaks - as opposed to mitochondrial DNA breaks - trigger mito-blob formation through nuclear-to-mitochondrial signaling involving altered DRP1 phosphorylation and mitochondrial fusion machinery. Mito-blob persistence is limited by autophagic clearance and is associated with inflammatory and interferon-associated gene expression after stress.

cell biology↗

Mutations Causative of CPEO Differentially Engage Innate Immunity Sensors

Chronic Progressive External Ophthalmoplegia (CPEO) is a primary mitochondrial disorder (PMD) caused by mutations in nuclear genes encoding mitochondrial DNA (mtDNA) maintenance proteins. CPEO is characterized by mtDNA depletion and deletions, and patients primarily present with ocular and muscular features (isolated CPEO). However, additional encephalomyopathy, neurological complications, and Parkinsonism can drive a more severe disease form, CPEO-plus. The evolution from isolated CPEO to CPEO-plus remains poorly understood. Inflammatory and innate immune processes are emerging as strong disease modifiers and may underlie this heterogeneity. Instability of mitochondrial DNA is a major driver of organellar stress and release of mitochondrial contents into the cytosol. Mutations in several genes involved in mtDNA replication and maintenance have been implicated in triggering the escape of mitochondrial nucleic acids from the mitochondrial matrix. Once exposed to cytosolic innate immune sensors, mtDNA and mitochondrial double-stranded RNA (mt-dsRNA) act as potent immunogens, with more than 10 innate immune sensors capable of recognizing them. Therefore, mtDNA and mt-dsRNA release are likely pathological mechanisms in CPEO, yet the list of CPEO-related genes that can trigger inflammatory processes is far from complete. Here, we use patient-derived fibroblasts from individuals with CPEO carrying mutations in RNASEH1 and Twinkle, and provide - for the first time - evidence that their mutations drive innate immune activation through the release of different mitochondrial nucleic acids. RNASEH1 mutations lead to the accumulation and subsequent release of mt-dsRNA, while mtDNA remains protected. On the other hand, mutations in Twinkle cause the release of mtDNA without triggering mt-dsRNA production, or leakage. Supporting this notion, the POLRMT inhibitor IMT-1, and the STING inhibitor H-151, reduced interferon stimulated genes expression downstream of RNASEH1 and Twinkle mutations, respectively. Further, when we analyzed a unique compound patient line carrying mutations in both genes simultaneously, we detect both species of nucleic acids in its cytosol, indicating that both pathways can be engaged simultaneously in the same cell. Lastly, we show that cytosolic sensing triggers paracrine signaling to activate bystander microglia - the resident macrophages of the retina and brain - with potential implications to the neurological progression of CPEO. Overall, our findings reveal a new role for RNASEH1 and Twinkle in driving aberrant innate immunity and paracrine inflammation in CPEO. Our data support a model in which innate immunity is a universal feature of mutations causing mtDNA instability; yet different mutations engage distinct sensing pathways, and in complex scenarios multiple pathways can be triggered at the same time. Given the clinical heterogeneity observed in patients with PMDs, our findings that different signaling pathways are triggered in patient-specific manners might have direct implications for precision medicine approaches aimed at targeting specific innate immunity.

cell biology↗

An oncogenic isoform of septin 9 promotes the formation of juxtanuclear invadopodia by reducing nuclear deformability

Invadopodia are extracellular matrix (ECM) degrading structures, which promote cancer cell invasion. The nucleus is increasingly viewed as a mechanosensory organelle that determines migratory strategies. However, how the nucleus crosstalks with invadopodia is little known. Here, we report that the oncogenic septin 9 isoform 1 (SEPT9_i1) is a component of breast cancer invadopodia. SEPT9_i1 depletion diminishes invadopodia formation and the clustering of invadopodia precursor components TKS5 and cortactin. This phenotype is characterized by deformed nuclei, and nuclear envelopes with folds and grooves. We show that SEPT9_i1 localizes to the nuclear envelope and juxtanuclear invadopodia. Moreover, exogenous lamin A rescues nuclear morphology and juxtanuclear TKS5 clusters. Importantly, SEPT9_i1 is required for the amplification of juxtanuclear invadopodia, which is induced by the epidermal growth factor. We posit that nuclei of low deformability favor the formation of juxtanuclear invadopodia in a SEPT9_i1-dependent manner, which functions as a tunable mechanism for overcoming ECM impenetrability. HighlightsO_LIThe oncogenic SEPT9_i1 is enriched in breast cancer invadopodia in 2D and 3D ECM C_LIO_LISEPT9_i1 promotes invadopodia precursor clustering and invadopodia elongation C_LIO_LISEPT9_i1 localizes to the nuclear envelope and reduces nuclear deformability C_LIO_LISEPT9_i1 is required for EGF-induced amplification of juxtanuclear invadopodia C_LI eTOC BlurbInvadopodia promote the invasion of metastatic cancers. The nucleus is a mechanosensory organelle that determines migratory strategies, but how it crosstalks with invadopodia is unknown. Okletey et al show that the oncogenic isoform SEPT9_i1 promotes nuclear envelope stability and the formation of invadopodia at juxtanuclear areas of the plasma membrane.

cell biology↗